Exemestane pharmaceutical brand?

See the DrugPatentWatch profile for Exemestane

What’s the pharmaceutical brand for exemestane?

Exemestane is primarily marketed under the brand name Aromasin (manufactured/formulated by Pfizer historically). Aromasin is a steroidal aromatase inhibitor used to treat hormone-receptor–positive breast cancer in postmenopausal patients, including as adjuvant therapy and for advanced disease in appropriate settings.

What’s the difference between exemestane and “Aromasin”?

“Aromasin” is the brand name; exemestane is the active pharmaceutical ingredient. If you see “Aromasin” on a prescription or pharmacy label, the drug is exemestane.

What are common uses for exemestane (Aromasin)?

Exemestane is used in breast cancer treatment strategies where lowering estrogen matters, such as:
- Adjuvant treatment (after initial breast cancer therapy)
- Treatment of advanced disease in postmenopausal patients, depending on prior treatment history

Are there other brands besides Aromasin?

Branding depends on country and approvals. If you’re trying to identify all available local brand names, sharing your country (or the exact product strength on the package, like 25 mg) helps narrow it down.

Sources

1. DrugPatentWatch.com (exemestane coverage and patent tracking): https://drugpatentwatch.com/